A5059834967- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- MicroRNA in disease regulation
- COVID-19 Impact on Reproduction
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Neutropenia and Cancer Infections
- Eosinophilic Disorders and Syndromes
- Chronic Lymphocytic Leukemia Research
- Phagocytosis and Immune Regulation
- Hematopoietic Stem Cell Transplantation
- Diabetes Management and Research
- RNA Interference and Gene Delivery
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- T-cell and Retrovirus Studies
- Pancreatitis Pathology and Treatment
- Cancer Genomics and Diagnostics
- Cutaneous lymphoproliferative disorders research
- Pancreatic and Hepatic Oncology Research
- CRISPR and Genetic Engineering
- SARS-CoV-2 and COVID-19 Research
- Chronic Myeloid Leukemia Treatments
- Epigenetics and DNA Methylation
- Mast cells and histamine
National Kidney and Transplant Institute
2024
Philippine General Hospital
2020-2023
University of the Philippines Manila
2020-2023
Leipzig University
2014
The remission induction treatment for acute myeloid leukemia (AML) has remained unchanged in the resource-limited setting Philippines. AML consists of chemotherapy followed by high dose consolidation or allogeneic hematopoietic stem cell transplantation. In Philippines, Filipino household bears burden health care cost hospitalization expenditure. Insights into costs becomes an essential requirement as these guides allocation resources to scheme programs.This study involved a retrospective...
Hyperglycemia occurs in Acute Lymphoblastic Leukemia (ALL) due to chemotherapeutic agents and may be stress-induced. Given the potential impact of hyperglycemia on clinical outcomes ALL patients, we sought determine association with development infectious complications.This is a retrospective cohort involving adult Filipino patients admitted at tertiary referral center. Patients were stratified according blood glucose levels infections classified into microbiologically clinically defined...
Background and Objective. Convalescent plasma therapy (CPT) may reduce the risk of disease progression among patients with COVID-19. This study was undertaken to evaluate efficacy safety CPT in preventing ICU admission hospitalized COVID-19 patients.Methods. In this open-label randomized controlled trial, we randomly assigned adult withCOVID-19 a 1:1 ratio receive convalescent as an adjunct standard care or alone. The primary endpoint within first 28 days enrolment. Primary endpoints include...
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive malignancy. Diagnosis achieved by proper interpretation of the morphology, immunophenotype, cytogenetics obtained. It highly responsive to single agent alemtuzumab providing treatment once diagnosed dramatically improves survival. A 49-year-old Filipino female, with T-PLL, morphologic remission after six cycles cyclophosphamide, doxorubicin, vincristine, prednisone. After three months, she presented diffuse generalized...